Globus Medical, Inc. Class A Common Stock (GMED)
EBITDA Growth
34.05%
Quarterly · Period ending:
GMED EBITDA Growth
Year-over-year change vs the same period a year earlier
Latest reported34.05%period ending
Latest reported34.05%period ending
GMED Quarterly EBITDA YoY % (20.62% → 34.05%)
Year-over-year change
High-resolution chart · PNG
GMED ebitda growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | EBITDA Growth |
|---|---|
| 34.0529% | |
| 38.2581% | |
| 68.2179% | |
| 85.5394% | |
| 53.067% | |
| 93.5166% | |
| 49.5974% | |
| 34.285% | |
| 44.8392% | |
| 11.7896% | |
| 23.3548% | |
| 12.6755% | |
| 4.3721% | |
| 15.7521% | |
| 83.4491% | |
| 7.8538% | |
| 5.9879% | |
| -8.8169% | |
| -44.563% | |
| 5.1364% | |
| 872.6124% | |
| 65.0101% | |
| 25.4562% | |
| 16.8748% | |
| -118.2846% | |
| -12.7184% | |
| 11.3847% | |
| 17.9278% | |
| -2.2% | |
| -9.6812% | |
| -2.8633% | |
| 5.5385% | |
| 17.3195% | |
| 3.8057% | |
| 8.5332% | |
| 1.2179% | |
| 8.7273% | |
| 6.9189% | |
| -15.5747% | |
| -1.6668% | |
| 3.847% | |
| 14.2808% | |
| 52.1177% | |
| 16.7163% | |
| 16.2611% | |
| 15.9274% | |
| -1.5708% | |
| 16.0471% | |
| 8.3823% | |
| 10.8937% | |
| 26.2298% | |
| 8.7029% | |
| 0.7927% | |
| 3.4966% | |
| 10.0337% | |
| 2.7451% | |
| 21.7844% | |
| 20.6247% |